[Research Progress on Imaging Diagnosis of Non-small Cell Lung Cancer Which Invades Pleura or Chest Wall] [0.03%]
侵犯胸膜或胸壁的非小细胞肺癌影像诊断研究进展
Yue Wang,Zhiyong Yuan
Yue Wang
Accurate staging is the fundamental basis for the treatment and prognosis of non-small cell lung cancer (NSCLC), and whether the tumor involves the pleura or chest wall is a critical aspect in assessing the staging of peripheral lung cancer...
[FCN3 Can Serve as A Potential Biomarker for Prognosis and Immunotherapy of Lung Squamous Cell Carcinoma] [0.03%]
FCN3可以用作肺鳞状细胞癌预后和免疫治疗的潜在生物标志物
Wei Li,Lingling Zu,Song Xu
Wei Li
Background: Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. Lung squamous cell carcinoma (LUSC) is an important pathological subtype of NSCLC. The complex immune escape mechanis...
[Exploration of the Predictive Value of Peripheral Blood-related Indicators for EGFR Mutations and Prognosis in Non-small Cell Lung Cancer Using Machine Learning] [0.03%]
[探索使用机器学习预测非小细胞肺癌中EGFR突变和预后的外周血相关指标的价值]
Shulei Fu,Shaodi Wen,Jiaqiang Zhang et al.
Shulei Fu et al.
Background: Epidermal growth factor receptor (EGFR) sensitive mutation is one of the effective targets of targeted therapy for non-small cell lung cancer (NSCLC). However, due to the difficulty of obtaining some primary t...
[Chinese Expert Consensus on Assessment and Clinical Application of Tertiary Lymphoid Structure for Non-small Cell Lung Cancer (2025 Version)] [0.03%]
《三级淋巴结构在非小细胞肺癌中的评估及临床应用中国专家共识（2025版）》
Lung Cancer Collaboration Group of Tumor Pathology Committee of Chinese Anti-Cancer Association;Expert Committee on Non-small Cell Lung Cancer of Chinese Society of Clinical Oncology
Lung Cancer Collaboration Group of Tumor Pathology Committee of Chinese Anti-Cancer Association;Expert Committee on Non-small Cell Lung Cancer of Chinese Society of Clinical Oncology
The tertiary lymphoid structure (TLS) plays a crucial role in the tumor microenvironment, influencing tumor development and progression. As an emerging biomarker for predicting the prognosis and treatment response in cancer patients, TLS ha...
[Expert Consensus on Diagnosis and Treatment of NSCLC with MET Abnormalities (2025 Version)] [0.03%]
《MET异常NSCLC诊治专家共识(2025版)》
Jun Chen,Baohui Han,Yi Hu et al.
Jun Chen et al.
The mesenchymal-epithelial transition factor (MET) gene, located on human chromosome 7, plays a crucial role in the regulation of physiological processes such as cell proliferation, migration, invasion, and angiogenesis. The MET gene is one...
[A Case Report of Lung Adenocarcinoma with EGFR G719A Mutation and LMNA-NTRK1 Fusion] [0.03%]
一例EGFR G719A突变和LMNA-NTRK1融合的肺腺癌报告
Shiqi Song,Yaxian Yang,Weiquan Luo et al.
Shiqi Song et al.
Fusion variations of neurotrophic receptor tyrosine kinase (NTRK) are oncogenic drivers in various solid tumors such as breast cancer, salivary gland carcinoma, infant fibrosarcoma, etc. Gene rearrangements involving NTRK1/2/3 lead to const...
[Intestinal Flora Dysregulation and Lung Cancer: Mechanism Analysis and Clinical Application] [0.03%]
肠道菌群失调与肺癌：机制分析及临床应用
Liangyuan Chen,Yiqing Xie,Chong Li
Liangyuan Chen
Lung cancer is the deadliest form of cancer globally, with millions of new cases diagnosed each year. Although rapid advancements in surgical techniques, targeted therapies, and immunotherapy have significantly improved patient outcomes, th...
[Dual Roles of Neutrophil Extracellular Traps in Lung Cancer: Mechanism Exploration and Therapeutic Prospects] [0.03%]
中性粒细胞胞外陷阱在肺癌中的双重角色：机制探索和治疗展望
Chengdao Li,Dongge Peng,Wei Sun
Chengdao Li
Lung cancer is one of the most common and lethal malignancies in China. In the context of the tumor microenvironment, neutrophil extracellular traps (NETs) released by neutrophils exert a profound impact on the occurrence and progression of...
[Research Progress of Tumor-associated Neutrophils in the Occurrence and Development of Lung Cancer] [0.03%]
肿瘤相关中性粒细胞在肺癌发生发展中的研究进展
Xiaoyan Li,Jianjun Zhou,Chaoting Zhao et al.
Xiaoyan Li et al.
Lung cancer is the malignant tumor with the highest mortality rate worldwide. The tumor microenvironment (TME) is a key factor in the progression of lung cancer, composed of tumor cells, signaling molecules, fibroblasts, immune cells, etc. ...
[Exploration and Challenge of Whole Course Follow-up Management Model for Small Cell Lung Cancer] [0.03%]
小细胞肺癌全程管理模式的探索与挑战
Chengming Huang,Yongzhao Zhou,Jing Xu et al.
Chengming Huang et al.
Small cell lung cancer (SCLC) is a highly malignant disease that has garnered significant attention in terms of treatment modalities and course management. Gaining an understanding of the clinical characteristics of SCLC, acquiring proficie...